sms pharma, indswift , bal pharma, jb chemichal
these are good pick
On Wed, Aug 25, 2010 at 7:51 PM, [email protected]
<[email protected]>wrote:
> Dear mr prabakar,
> what are the views on the sensex for the next 2 quarters
> Cheers,
> Equity Monk
>
> Sent from my Nokia E-72 Enterprise Edition SmartPhone.-----Original
> Message-----
> From: Prabhakar A.K
> Sent: 24/08/2010, 7:44 AM
> To:
> Subject: {GS} CRAMS stocks doing well-A.K.Prabhakar
>
>
> http://iupindia.in/810/AN_CRAMS_India_50.html India is a low-cost hub for
> Contract Research and Manufacturing Services (CRAMS), and with many Big
> Pharma companies finding it difficult to grow, focus is shifting towards
> India. Indian CRAMS players enjoying strong relationships with Big Pharma
> would be the key beneficiaries of the CRO vendor consolidation expected
> post-restructuring at Big Pharma. 2010 will likely witness a turnaround in
> the fortunes of Indian CRAMS players.
>
>
>
> http://hindi.economictimes.indiatimes.com/articleshow/6319013.cms *ए**
> **के*
> * **प्रभाकर**, **स्वतंत्र** **तकनीकी** **विश्लेषक*
>
> * *
>
> http://akprabhakar.blogspot.com/2010/08/crams-stocks-doing-well.html
> JUBILANT & GLENMARK we have in FAB15
>
> [image: GLENMARK.JPEG]
>
>
>
> *Regards*
>
>
>
> A.K.Prabhakar
>
>
>
> Equity Analyst
>
>
>
> [email protected]
>
> [email protected]
>
>
>
> www.akprabhakar.com
>
>
>
> *Disclaimer:*
>
> This represents views based purely on Technical studies. The information
> and
> views presented in this report are prepared by A K Prabhakar. The
> information contained herein is based on my analysis of the Charts and upon
> sources that I consider reliable. I, however, do not vouch for the accuracy
> or the completeness thereof. This material is for personal information and
> I
> am not responsible for any loss incurred based upon it. The investments
> discussed or recommended in this report may not be suitable for all
> investors. Investors must make their own investment decisions based on
> their
> specific investment objectives and financial position and using such
> independent advice, as they believe necessary. While acting upon any
> information or analysis mentioned in this report, investors may please note
> that neither A K Prabhakar nor any person connected with him accepts any
> liability arising from the use of this information and views mentioned in
> this document. A K Prabhakar and his affiliates may hold long or short
> positions in the above-mentioned companies from time to time. The report is
> intended for a restricted audience and I am not soliciting any action based
> on it. Neither the information nor any opinion expressed herein constitutes
> an offer or an invitation to make an offer, to buy or sell any securities,
> or any options, futures or other derivatives related to such securities.
>
> --
> You received this message because you are subscribed to the Google Groups
> ""GLOBAL SPECULATORS"" group.
> To post to this group, send email to [email protected].
> To unsubscribe from this group, send email to
> [email protected]<globalspeculators%[email protected]>
> .
> For more options, visit this group at
> http://groups.google.com/group/globalspeculators?hl=en.
>
>
> --
> You received this message because you are subscribed to the Google Groups
> ""GLOBAL SPECULATORS"" group.
> To post to this group, send email to [email protected].
> To unsubscribe from this group, send email to
> [email protected]<globalspeculators%[email protected]>
> .
> For more options, visit this group at
> http://groups.google.com/group/globalspeculators?hl=en.
>
>
--
You received this message because you are subscribed to the Google Groups
""GLOBAL SPECULATORS"" group.
To post to this group, send email to [email protected].
To unsubscribe from this group, send email to
[email protected].
For more options, visit this group at
http://groups.google.com/group/globalspeculators?hl=en.
